Literature DB >> 17957994

[The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season].

J C de Jong1, G F Rimmelzwaan, G A Donker, A Meijer, R A M Fouchier, A D M E Osterhaus.   

Abstract

The influenza epidemic of 2006/'07 began late in the season, like the two previous influenza epidemics. In week 8 a peak of modest height was reached. As usual, the causal strains were mainly A/H3N2 viruses and to a lesser extent A/H1N1 and B viruses. A new A/H1N1 virus variant has emerged, an event that on average takes place only every 10 years. However, almost all A/H1N1 virus isolates belonged to the old variant and were similar to the vaccine virus. The A/H3N2 virus isolates appeared to deviate from the vaccine strain, but after antigenic cartographic analysis and correction for low avidity they proved also closely related to the vaccine strain. The few type B virus isolates belonged to the B/Yamagata/16/88 lineage, whereas the used B vaccine virus had been chosen from the B/Victoria/2/87 lineage. The vaccine therefore will have provided almost optimal protection against the circulating influenza A/H1N1 and A/H3N2 viruses but not against the influenza B viruses. For the 2007/'08 influenza season the World Health Organization has recommended the following vaccine composition: A/Solomon Islands/3/06 (H1N1) (new), A/Wisconsin/67/05 (H3N2), and B/Malaysia/2506/04.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957994

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  5 in total

1.  Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

Authors:  R Bodewes; G de Mutsert; F R M van der Klis; M Ventresca; S Wilks; D J Smith; M Koopmans; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Clin Vaccine Immunol       Date:  2011-01-05

2.  Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.

Authors:  Maryam Darvishian; Frederika Dijkstra; Eva van Doorn; Maarten J Bijlsma; Gé A Donker; Marit M A de Lange; Laura M Cadenau; Eelko Hak; Adam Meijer
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

3.  Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.

Authors:  Eva van Doorn; Maryam Darvishian; Frederika Dijkstra; Gé A Donker; Pieter Overduin; Adam Meijer; Eelko Hak
Journal:  Vaccine       Date:  2017-04-12       Impact factor: 3.641

4.  Early occurrence of influenza A epidemics coincided with changes in occurrence of other respiratory virus infections.

Authors:  Liselotte van Asten; Paul Bijkerk; Ewout Fanoy; Annemarijn van Ginkel; Anita Suijkerbuijk; Wim van der Hoek; Adam Meijer; Harry Vennema
Journal:  Influenza Other Respir Viruses       Date:  2016-01       Impact factor: 4.380

5.  Effect of travel on influenza epidemiology.

Authors:  Sanne-Meike Belderok; Guus F Rimmelzwaan; Anneke van den Hoek; Gerard J B Sonder
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.